Article Information
History
- December 16, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- João Fadista1,2,3,*,
- Luke M. Kraven4,
- Juha Karjalainen3,5,6,
- Shea J. Andrews7,
- Frank Geller1,
- The COVID-19 Host Genetics Initiative,
- J Kenneth Baillie8,9,
- Louise V. Wain4,10,
- R. Gisli Jenkins11,12 and
- Bjarke Feenstra1
- 1Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark
- 2Department of Clinical Sciences, Lund University Diabetes Centre, Malmö, Sweden
- 3Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland
- 4Department of Health Sciences, University of Leicester, Leicester, UK
- 5Massachusetts General Hospital, Boston, Massachusetts, USA
- 6Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA
- 7Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 8Roslin Institute, University of Edinburgh, Edinburgh, UK
- 9Intensive Care Unit, Royal Infirmary of Edinburgh, Edinburgh, UK
- 10NIHR, Leicester Respiratory, Biomedical Research Centre, Glenfield Hospital, Leicester, UK
- 11Nottingham University Hospitals NHS Trust, City Campus, Nottingham, UK
- 12NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK
- ↵* Corresponding author; email: jpsf{at}ssi.dk